All Stories

  1. Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents

    Article • Pharmaceutics, January 2024, MDPI AG

    Dr Ronald Vender

  2. The Role of IL-17 in Papulopustular Rosacea and Future Directions

    Article • Journal of Cutaneous Medicine and Surgery, August 2019, SAGE Publications

    Dr Ronald Vender

  3. Canadian Patients’ Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys

    Article • Journal of Cutaneous Medicine and Surgery, May 2018, SAGE Publications

    Dr Ronald Vender

  4. Psoriasis patients’ preference for an aerosol foam topical formulation

    Article • Journal of the European Academy of Dermatology and Venereology, May 2018, Wiley

    Dr Ronald Vender

  5. Effect of secukinumab on quality of life and psoriasis-related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52-week study

    Article • Journal of the American Academy of Dermatology, April 2018, Elsevier

    Dr Ronald Vender

  6. Survival of the fittest

    Article • British Journal of Dermatology, February 2018, Wiley

    Dr Ronald Vender

  7. Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies

    Article • Dermatology and Therapy, December 2017, Springer Science + Business Media

    Dr Ronald Vender

  8. Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice

    Article • British Journal of Dermatology, November 2017, Wiley

    Joelle van der Walt, Dr Jashin J Wu, Dr Ronald Vender

  9. A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in Adults

    Article • Journal of Cutaneous Medicine and Surgery, October 2017, SAGE Publications

    Dr Ronald Vender

  10. Acitretin use in Dermatology.

    Article • Journal of Cutaneous Medicine and Surgery, September 2017, SAGE Publications

    Lyn Guenther, Dr Ronald Vender

  11. Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition

    Article • Journal of Cutaneous Medicine and Surgery, August 2017, SAGE Publications

    Dr Ronald Vender

  12. Undergraduate Dermatology Education in Canada: A National Survey

    Article • Journal of Cutaneous Medicine and Surgery, August 2017, SAGE Publications

    Dr Ronald Vender

  13. Biosimilars for psoriasis: clinical studies to determine similarity

    Article • British Journal of Dermatology, May 2017, Wiley

    Dr Ronald Vender

  14. An Open Letter to Health Canada

    Article • Journal of Cutaneous Medicine and Surgery, May 2017, SAGE Publications

    Dr Ronald Vender

  15. Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice

    Article • The Journal of Rheumatology, April 2017, The Journal of Rheumatology

    Dr Ronald Vender

  16. Review of Systemic Treatment Options for Adult Atopic Dermatitis

    Article • Journal of Cutaneous Medicine and Surgery, January 2017, SAGE Publications

    Dr Ronald Vender

  17. Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study

    Article • Journal of the American Academy of Dermatology, January 2017, Elsevier

    Dr Ronald Vender

  18. Effect of tofacitinib withdrawal and re-treatment on patient-reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis

    Article • Journal of the European Academy of Dermatology and Venereology, September 2016, Wiley

    Dr Ronald Vender

  19. 2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009

    Article • Journal of Cutaneous Medicine and Surgery, July 2016, SAGE Publications

    Dr Ronald Vender

  20. Acral Hemorrhagic Darier’s Disease

    Article • Journal of Cutaneous Medicine and Surgery, July 2016, SAGE Publications

    Dr Ronald Vender

  21. Psoronychomycosis: A New Term for an Old Problem

    Article • Journal of Cutaneous Medicine and Surgery, March 2016, SAGE Publications

    Dr Ronald Vender

  22. Biosimilars for psoriasis: preclinical analytical assessment to determine similarity

    Article • British Journal of Dermatology, December 2015, Wiley

    Joelle van der Walt, Dr Ronald Vender

  23. Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials

    Article • The Lancet, August 2015, Elsevier

    Dr Kim A Papp, Dr Ronald Vender

  24. Non-melanoma Skin Cancer in Canada Chapter 1: Introduction to the Guidelines

    Article • Journal of Cutaneous Medicine and Surgery, May 2015, SAGE Publications

    Dr Ronald Vender

  25. Non-melanoma Skin Cancer in Canada Chapter 2: Primary Prevention of Non-melanoma Skin Cancer

    Article • Journal of Cutaneous Medicine and Surgery, May 2015, SAGE Publications

    Dr Ronald Vender

  26. Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses

    Article • Journal of Cutaneous Medicine and Surgery, May 2015, SAGE Publications

    Dr Ronald Vender

  27. Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma

    Article • Journal of Cutaneous Medicine and Surgery, May 2015, SAGE Publications

    Dr Ronald Vender

  28. Non-melanoma Skin Cancer in Canada Chapter 5: Management of Squamous Cell Carcinoma

    Article • Journal of Cutaneous Medicine and Surgery, May 2015, SAGE Publications

    Dr Ronald Vender

  29. Paradoxical, Cupping-Induced Localized Psoriasis: A Koebner Phenomenon

    Article • Journal of Cutaneous Medicine and Surgery, March 2015, SAGE Publications

    Dr Ronald Vender

  30. Public Engagement with Dermatology Contents on Facebook

    Article • Journal of Cutaneous Medicine and Surgery, March 2015, SAGE Publications

    Dr Ronald Vender

  31. Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab

    Article • Journal of the European Academy of Dermatology and Venereology, January 2015, Wiley

    Dr Ronald Vender

  32. Think beyond the Skin

    Article • Journal of Cutaneous Medicine and Surgery, January 2015, SAGE Publications

    Dr Ronald Vender

  33. Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)

    Article • British Journal of Dermatology, December 2014, Wiley

    Dr Ronald Vender

  34. A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin

    Article • British Journal of Dermatology, October 2014, Wiley

    Dr Ronald Vender

  35. Use of Facebook as a Tool for Knowledge Dissemination in Dermatology

    Article • Journal of Cutaneous Medicine and Surgery, September 2014, SAGE Publications

    Dr Ronald Vender

  36. Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, July 2014, New England Journal of Medicine (NEJM/MMS)

    Dr Kim A Papp, Dr Ronald Vender

  37. Interleukin 17A: Toward a new understanding of psoriasis pathogenesis

    Article • Journal of the American Academy of Dermatology, July 2014, Elsevier

    Dr Ronald Vender

  38. A Consensus on Acne Management Focused on Specific Patient Features

    Article • Journal of Cutaneous Medicine and Surgery, July 2014, SAGE Publications

    Dr Ronald Vender

  39. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

    Article • The Lancet, August 2013, Elsevier

    M.D.,Ph.D. Rubén Queiro, Dr Ronald Vender

  40. One-Year, Multicenter, Open-Label, Single-Arm Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Moderate-to-Severe Plaque Psoriasis in a Canadian Population

    Article • Journal of Cutaneous Medicine and Surgery, March 2013, SAGE Publications

    Dr Ronald Vender

  41. Sulfa or Sulfur? Clearing Things up

    Article • Journal of Cutaneous Medicine and Surgery, March 2013, SAGE Publications

    Dr Ronald Vender

  42. Etanercept Improves Quality of Life Outcomes and Treatment Satisfaction in Patients with Moderate to Severe Plaque Psoriasis in Clinical Practice

    Article • Journal of Cutaneous Medicine and Surgery, November 2012, SAGE Publications

    Dr Ronald Vender

  43. Work Productivity and Healthcare Resource Utilization Outcomes for Patients on Etanercept for Moderate-to-Severe Plaque Psoriasis

    Article • Applied Health Economics and Health Policy, September 2012, Springer Science + Business Media

    Dr Ronald Vender

  44. Work Productivity and Healthcare Resource Utilization Outcomes for Patients on Etanercept for Moderate-to-Severe Plaque Psoriasis

    Article • Applied Health Economics and Health Policy, September 2012, Springer Science + Business Media

    Dr Ronald Vender

  45. Comparison of Dermatologists' and Nondermatologists' Diagnostic Accuracy for Malignant Melanoma

    Article • Journal of Cutaneous Medicine and Surgery, July 2012, SAGE Publications

    Dr Ronald Vender

  46. Erythema ab igne caused by laptop computer gaming - a case report

    Article • International Journal of Dermatology, May 2012, Wiley

    Dr Ronald Vender

  47. Double-Blinded, Vehicle-Controlled Proof of Concept Study to Investigate the Recurrence of Inflammatory and Noninflammatory Acne Lesions Using Tretinoin Gel (Microsphere) 0.04% in Male Patients after Oral Isotretinoin Use

    Article • Dermatology Research and Practice, January 2012, Hindawi Publishing Corporation

    Dr Ronald Vender

  48. Topical Psoriasis Therapy in the Age of Biologics: Evidence-Based Treatment Recommendations

    Article • Journal of Cutaneous Medicine and Surgery, November 2011, SAGE Publications

    Dr Ronald Vender

  49. Canadian Guidelines for the Management of Plaque Psoriasis: Overview

    Article • Journal of Cutaneous Medicine and Surgery, July 2011, SAGE Publications

    Dr Ronald Vender

  50. Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet

    Article • Archives of Dermatology, April 2011, American Medical Association (AMA)

    Dr Kim A Papp, Dr Ronald Vender

  51. Systemic Role for Vitamin D in the Treatment of Psoriasis and Metabolic Syndrome

    Article • Dermatology Research and Practice, January 2011, Hindawi Publishing Corporation

    Dr Ronald Vender

  52. Gourmet Clinical Pearls

    Article • Journal of Cutaneous Medicine and Surgery, January 2011, SAGE Publications

    Dr Ronald Vender

  53. Quality of life in plaque psoriasis patients treated with voclosporin: a Canadian phase III, randomized, multicenter, double-blind, placebo-controlled study

    Article • European Journal of Dermatology, January 2011, John Libbey Eurotext

    Dr Ronald Vender

  54. Drug-Induced Lichenoid Dermatitis with Histopathologic Features of Mycosis Fungoides in a Patient with Psoriasis

    Article • Journal of Cutaneous Medicine and Surgery, November 2010, SAGE Publications

    Dr Ronald Vender

  55. Are Excipients Really Inert Ingredients? A Review of Adverse Reactions to Excipients in Oral Dermatologic Medications in Canada

    Article • Journal of Cutaneous Medicine and Surgery, May 2010, SAGE Publications

    Dr Ronald Vender

  56. Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasis

    Article • Journal of Dermatological Treatment, February 2010, Taylor & Francis

    Dr Ronald Vender

  57. Efficacy Outcomes in Patients Using Alefacept in the AWARE Study

    Article • Journal of Cutaneous Medicine and Surgery, November 2009, SAGE Publications

    Dr Ronald Vender

  58. Adalimumab in the Treatment of Psoriasis: Pooled Efficacy and Safety Results from Three Pivotal Studies

    Article • Journal of Cutaneous Medicine and Surgery, September 2009, Decker, Inc.

    Dr Kim A Papp, Dr Ronald Vender

  59. Nail Psoriasis and Biologics

    Article • Journal of Cutaneous Medicine and Surgery, January 2009, SAGE Publications

    Dr Ronald Vender

  60. Occurrence of Plantar Pustular Psoriasis during Treatment with Infliximab

    Article • Journal of Cutaneous Medicine and Surgery, January 2009, SAGE Publications

    Dr Ronald Vender

  61. Practical Understanding of Mean Percent Psoriasis Area and Severity Index Reduction for Biologics

    Article • Journal of Cutaneous Medicine and Surgery, November 2008, SAGE Publications

    Dr Ronald Vender

  62. Are All Seborrheic Keratoses Benign? Review of the Typical Lesion and Its Variants

    Article • Journal of Cutaneous Medicine and Surgery, September 2008, SAGE Publications

    Dr Ronald Vender

  63. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

    Article • The Lancet, May 2008, Elsevier

    Dr Ronald Vender

  64. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial

    Article • British Journal of Dermatology, May 2008, Wiley

    Dr Ronald Vender

  65. Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy

    Article • Journal of the American Academy of Dermatology, July 2007, Elsevier

    Dr Ronald Vender

  66. Miliarial Gout (A New Entity)

    Article • Journal of Cutaneous Medicine and Surgery, January 2007, SAGE Publications

    Dr Ronald Vender

  67. Multitherapy Approach to Onychomycosis Therapy

    Article • Journal of Cutaneous Medicine and Surgery, November 2006, SAGE Publications

    Dr Ronald Vender

  68. Prevalence and Epidemiology of Onychomycosis

    Article • Journal of Cutaneous Medicine and Surgery, November 2006, SAGE Publications

    Dr Ronald Vender

  69. Cutaneous Reaction to Drugs Used for Erectile Dysfunction: Case Report and Review of the Literature

    Article • Journal of Cutaneous Medicine and Surgery, May 2006, SAGE Publications

    Dr Ronald Vender

  70. Use of Calcipotriene Cream (Dovonex?? Cream) Following Acute Treatment of Psoriasis Vulgaris with the Calcipotriene/Betamethasone Dipropionate Two-Compound Product (Taclonex??)

    Article • American Journal of Clinical Dermatology, January 2006, Springer Science + Business Media

    Dr Ronald Vender

  71. Antihistamines in the Treatment of Atopic Dermatitis

    Article • Journal of Cutaneous Medicine and Surgery, November 2003, SAGE Publications

    Dr Ronald Vender

  72. Pharmacology of TNF inhibitors

    Article • Springer Science + Business Media

    Dr Ronald Vender